Endocrine Abstracts

Somatostatin analogues (SA) represent the most effective medical treatment for the control of neuroendocrine tumour (NET) symptoms, like carcinoid syndrome. Recently there has been evidence of lengthened time to tumour progression in patients with midgut carcinoid treated with octreotide. Nevertheless, a number of new therapeutic indications and the clinical effectiveness of SA for other clinical conditions are appearing. A 69-year-old man was investigated for anaemia (haemogl...

Introduction: Pancreatic neuroendocrine tumours (pNETs) can either occur in patients with a familial syndrome, like multiple endocrine neoplasia type 1 (MEN-1), or being sporadic. In the last decade, endoscopic ultrasound (EUS) has become one of the first-line investigations for the characterisation of pNETs. The ultrasonographic features of a pNET might differ depending on the familial vs sporadic pathogenesis of the tumour. Therefore, the EUS findings might help and direct t...